Concepedia

Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study

Ayako Tominaga, Keiji Wada, Ken Okazaki, Hideharu Nishi, Yasushi Terayama, Yoshiharu Kato

Osteoporosis International · 2021 · 43 citations · 17 references

DOIFull text

Open access

Concepts

References

17

A method for estimating the probability of adverse drug reactions

C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations

, , +17

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi et al. · New England Journal of Medicine · 2016 · 1.7K citations · Full text

, , +17

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag, Jeffrey Petersen, Maria Luisa Brandi et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

, , +16

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, Andreas Grauer, Steven Boonen et al. · New England Journal of Medicine · 2014 · 1.2K citations

, , +12

Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study

Noriko Yoshimura, Shigeyuki Muraki, Hiroyuki Oka et al. · Journal of Bone and Mineral Metabolism · 2009 · 820 citations

, , +17